Novo Nordisk's pricing approaches within the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who may have accused the company of price tag gouging, stating the stark distinction in between U.S. price ranges and those in Europe and copyright. Thank you for reaching out